BMRN
Biomarin Pharmaceutical Inc
63.90$
-1.8%
vs. previous close
Closing price · As of: Sep 18, 2026
Filings
Filings
Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Biomarin Pharmaceutical Inc (BMRN) with date, type and a link to the original document.
| Date | Type | Filing | Original |
|---|---|---|---|
| 09/15/2026 | Current report (8-K) | BIOMARIN PHARMACEUTICAL INC (BMRN): Other Events | View report ↗ |
| 09/14/2026 | Current report (8-K) | BIOMARIN PHARMACEUTICAL INC (BMRN): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers | View report ↗ |
| 09/02/2026 | Insider sale notice | Form 144 filed with the SEC | View document ↗ |
| 09/01/2026 | Current report (8-K) | BIOMARIN PHARMACEUTICAL INC (BMRN): Other Events | View report ↗ |
| 08/31/2026 | Current report (8-K) | BIOMARIN PHARMACEUTICAL INC (BMRN): Entry into a Material Definitive Agreement; Regulation FD Disclosure; Financial Statements and Exhibits | View report ↗ |
| 08/18/2026 | Current report (8-K) | BIOMARIN PHARMACEUTICAL INC (BMRN): Entry into a Material Definitive Agreement; Regulation FD Disclosure; Financial Statements and Exhibits | View report ↗ |
| 08/06/2026 | Current report (8-K) | BIOMARIN PHARMACEUTICAL INC (BMRN): Results of Operations and Financial Condition; Financial Statements and Exhibits | View report ↗ |
Showing the 100 most recent filings of the selected type.
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.